IBA aims to become a global provider of health IT solutions. This is exemplified by the acquisition of iSOFT, expanding its scope to 35 countries. The group will refocus in three markets under the iSOFT brand: iSOFT financials, iSOFT healthcare and iSOFT Consumer. Healthcare spending is driven by the increased demand for access to healthcare services and an ageing population. Geographically, cross selling opportunities exists in the UK while IBA will continue to grow into new markets in Southern Europe, Russia, Middle East, China and Latin America.
IBA Price at posting:
75.3¢ Sentiment: LT Buy Disclosure: Held